Cargando…
Pharmacologic Complement Inhibition in Clinical Transplantation
PURPOSE OF REVIEW: Over the past two decades, significant strides made in our understanding of the etiology of antibody-mediated rejection (AMR) in transplantation have put the complement system in the spotlight. Here, we review recent progress made in the field of pharmacologic complement inhibitio...
Autores principales: | Tatapudi, Vasishta S., Montgomery, Robert A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707230/ https://www.ncbi.nlm.nih.gov/pubmed/29214126 http://dx.doi.org/10.1007/s40472-017-0148-7 |
Ejemplares similares
-
Nuclear Factor of Activated T Cell-regulated Cytokine Gene Expression for Adjustment of Tacrolimus in Kidney Transplant Recipients: A Randomized Controlled Pilot Trial
por: Webber, Allison B., et al.
Publicado: (2018) -
Robotic-assisted Kidney Transplantation: Our Experience and Literature Review
por: Tzvetanov, Ivo, et al.
Publicado: (2015) -
Donor-derived Cell-free DNA Complements De Novo Class II DSA in Detecting Late Alloimmune Injury Post Kidney Transplantation
por: Butiu, Maria, et al.
Publicado: (2022) -
Population-based Trends in Obesity and Kidney Transplantation Among Patients With End-stage Kidney Disease
por: Wakam, Glenn K., et al.
Publicado: (2021) -
Therapeutic Modulation of the Complement System in Kidney Transplantation: Clinical Indications and Emerging Drug Leads
por: Tatapudi, Vasishta S., et al.
Publicado: (2019)